<DOC>
	<DOCNO>NCT02034201</DOCNO>
	<brief_summary>Methamphetamine dependence serious public health problem , methamphetamine abuser risk significant morbidity mortality , include HIV . To date , medication psychotherapeutic strategy show robust , long-term efficacy treat disorder . This clinical trial examine whether lisdexamfetamine show promise alleviate withdrawal symptom prevent relapse relative placebo recently-abstinent methamphetamine dependent individual . Findings study shed light whether lisdexamfetamine may improve upon treatment disorder also inform future medication development strategy improve treatment drug dependence disorder . Discovering efficacious limited risk intervention show robust , longer-term outcome would beneficial individual society .</brief_summary>
	<brief_title>Clinical Efficacy Lisdexamfetamine Methamphetamine Dependence</brief_title>
	<detailed_description />
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>1 . Age ( 1865 yr ) . 2 . Participants must fulfill DSMIV criterion Methamphetamine dependence These criterion ascertain follow manner : physician determine whether individual appropriate base clinical assessment patient also need meet criterion methamphetamine dependence base administration SCID . 3 . Selfreported average METH use least 250 mg methamphetamine per occasion least weekly precede 3month period . 4 . A positive urine toxicology screen methamphetamine . Participants must submit urine sample negative drug abuse ( opiate , benzodiazepine , cocaine PCP ) methamphetamine marijuana week prior start study . 5 . Women childbearing potential include provided 1 ) negative pregnancy test , 2 ) agree adequate contraception ( tubal ligation , hysterectomy , barrier contraceptive method oral contraceptive method ) prevent pregnancy study 3 ) nursing . 6 . Normal blood pressure SBP &gt; 89 &lt; 141 , DBP &gt; 59 &lt; 91 . 1 . Current suicidality psychosis 2 . Current cocaine dependence opioid , alcohol , sedative physical dependence 3 . Major hepatic cardiovascular disorder ( include history myocardial infarction , cardiovascular disease , history currently clinically significant ECG abnormality ) unstable medical condition contraindicates study participation 4 . History schizophrenia bipolar type I disorder 5 . Use medication would expect major interaction LDX include psychotropics 6 . Medical contraindication receive LDX 7 . Positive drug screen cocaine , opiates , sedatives PCP . 8 . History Seizure disorder 9 . Documented hypersensitivity sympathomimetic amine 10 . LFT &gt; 3xULN 11 . Pregnancy/nursing 12 . Current use past 2 week use MAOi 13 . History Narrowangle glaucoma g.n . History Hyperthyroidism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>